Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06472271

Colistin Dosage Prsonalization Approach

Sponsor: Mahmoud I Mostafa

View on ClinicalTrials.gov

Summary

A few studies have evaluated higher doses or the administration or a loading dose, which is routine in adults, in pediatric patients, and reported improved colistin exposure without an increased risk of nephrotoxicity The main questions it aims to answer are What is the optimal dosing strategies of intravenous colistin for the treatment of multidrug-resistant gram-negative bacterial infections in preterm neonates? What is the incidence of AKI? What is the factors increasing AKI incidence? A single center retrospective and comparative study, cohort study compare low dose 5 mg/kg/day versus 7.5mg/kg/day

Official title: Colistin in Neonatal ICU Patients With Gram Negative Resistant Infection: Dosage Personalization Approach

Key Details

Gender

All

Age Range

0 Days - 28 Days

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2024-07-30

Completion Date

2025-10-30

Last Updated

2025-08-13

Healthy Volunteers

No

Interventions

DRUG

Polymyxin e

Increased starting colistin dose

Locations (1)

Cairo univrsity Hospitals

Cairo, Egypt